Blood-brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy

Mariel G Kozberg1,2, Irvin Yi3, Whitney M Freeze4,5

  • 1MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129, USA.

Brain Communications
|October 21, 2022
PubMed

Insights

Cerebral amyloid angiopathy involves blood-brain barrier leakage and inflammation, leading to vascular remodelling and hemorrhage. Early leakage may trigger inflammation, contributing to this small vessel disease.

Area of Science:

  • Neurology
  • Vascular Biology
  • Pathology

Background:

  • Cerebral amyloid angiopathy (CAA) is a small vessel disease linked to microbleeds and lobar intracerebral hemorrhage.
  • Amyloid-beta deposition in cerebral arterioles is characteristic of CAA.
  • Mechanisms underlying CAA-related hemorrhage are not fully understood.

Purpose of the Study:

  • To investigate the roles of blood-brain barrier (BBB) leakage and perivascular inflammation in CAA-related vascular remodelling.
  • To examine arterioles at different stages of CAA pathology.

Main Methods:

  • Autopsy tissue from seven CAA cases and five control cases were analyzed.
  • Immunohistochemistry was used to detect amyloid-beta, fibrinogen, smooth muscle actin, astrocytes, and microglia.
  • Vessels were graded for CAA severity, and BBB leakage and inflammation were assessed.

Main Results:

  • BBB leakage and smooth muscle actin loss were significantly increased in mild CAA (Grade 1) compared to controls (Grade 0).
  • BBB leakage was present in 100% of remodelled vessels (Grades 3-4).
  • Perivascular inflammation (astrocytes, microglia) was prominent around later-stage CAA vessels (Grades 2-4).

Conclusions:

  • BBB leakage and perivascular inflammation contribute to arteriolar remodelling and hemorrhage in CAA.
  • Early BBB leakage may initiate perivascular inflammation, driving CAA pathogenesis.